Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Alonso-Fernández, F. García-Río, M. A. Arias, A. Hernanz, M. De la Peña, J. Pierola, A. Barceló, A. Agustí García (Palma de Mallorca, Madrid, Toledo, Bunyola, Spain). A randomized, cross-over, placebo-controlled study of the effects of CPAP upon oxidative stress and nitrate deficiency in patients with obstructive sleep apnea syndrome. Eur Respir J 2008; 32: Suppl. 52, 846

Member's Comments

No comment yet.

Related content which might interest you: A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 A randomised, double-blind, crossover, placebo-controlled trial of a mandibular advancement device for the treatment of snoring and mild obstructive sleep apnoea-hypopnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002 Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study Source: Eur Respir J 2014; 44: 140-149 Year: 2014 Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019 Year: 2020 The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019 Year: 2019 Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005 Safety and efficacy of sulthiame in moderate to severe obstructive sleep apnea: a randomized placebo-controlled parallel-group trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Treatment of obstructive sleep apnea during decompensations of heart hailure a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN) Source: Eur Respir J, 58 (5) 2101937; 10.1183/13993003.01937-2021 Year: 2021 Treatment of mild obstructive sleep apnea syndrome (OSAS) with excessive daytime sleepiness: a randomised controlled single blind trial of CPAP versus nasal strips Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013 Effects of CPAP treatment on sex hormone levels in patients with obstructive sleep apnoea - data from two randomized, controlled trials Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects Year: 2019 Reduced hypoxic burden following carbonic anhydrase inhibition in obstructive sleep apnea – a randomized placebo-controlled study Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Economic arguments in favor of immediate management of patients with moderate-to-severe obstructive sleep apnea syndrome. A randomised controlled trial Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003 CPAP effects on leptin and visceral fat in patients with sleep apnea: Double-blind, randomized, controlled trial Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea Year: 2011 The use of modafinil in patients with obstructive apnoea-hyponoea syndrome (OAHS). A randomized, placebo-controlled, double-blind study Source: Eur Respir J 2001; 18: Suppl. 33, 419s Year: 2001 Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial Source: Eur Respir J, 51 (5) 1800032; 10.1183/13993003.00032-2018 Year: 2018 Acetazolamide improves cardiac dysrhythmias in patients with obstructive sleep apnea at altitude. A randomized controlled trial Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 Morphine alters respiratory control but not other key obstructive sleep apnoea phenotypes: a randomised trial Source: Eur Respir J, 55 (6) 1901344; 10.1183/13993003.01344-2019 Year: 2020 Efficacy of mandibular advancement appliance in moderate obstructive sleep apnea syndrome. A prospective randomised study Source: Annual Congress 2010 - The upper airway and oral appliances Year: 2010